Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Harnessing choice architecture in urologic practice: Implementation of an opioid-sparing protocol grounded in cognitive behavioral theory.
Bernstein AN, Nourian A, Strother M, Lobo A, Devarajan K, Richman D, Hill MV, Conrad L, Magagna A, Viterbo R, Greenberg R, Chen D, Smaldone M, Correa A, Uzzo R, Kutikov A. Bernstein AN, et al. Among authors: devarajan k. Urol Oncol. 2022 Mar;40(3):95-102. doi: 10.1016/j.urolonc.2021.10.011. Epub 2021 Dec 6. Urol Oncol. 2022. PMID: 34876350
Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members.
Sterious S, Simhan J, Uzzo RG, Gershman B, Li T, Devarajan K, Canter D, Walton J, Fogg R, Ginzburg S, Corcoran A, Smaldone MC, Kutikov A. Sterious S, et al. Among authors: devarajan k. J Urol. 2013 Sep;190(3):992-8. doi: 10.1016/j.juro.2013.03.076. Epub 2013 Mar 26. J Urol. 2013. PMID: 23538239
Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma.
Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, Liao L, Cho EA, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H. Jiang W, et al. Among authors: devarajan k. PLoS One. 2016 Oct 20;11(10):e0164554. doi: 10.1371/journal.pone.0164554. eCollection 2016. PLoS One. 2016. PMID: 27764136 Free PMC article.
Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence.
Franco-Barraza J, Francescone R, Luong T, Shah N, Madhani R, Cukierman G, Dulaimi E, Devarajan K, Egleston BL, Nicolas E, Katherine Alpaugh R, Malik R, Uzzo RG, Hoffman JP, Golemis EA, Cukierman E. Franco-Barraza J, et al. Among authors: devarajan k. Elife. 2017 Jan 31;6:e20600. doi: 10.7554/eLife.20600. Elife. 2017. PMID: 28139197 Free PMC article.
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.
Anari F, O'Neill J, Choi W, Chen DYT, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER. Anari F, et al. Among authors: devarajan k. Eur Urol Oncol. 2018 May;1(1):54-60. doi: 10.1016/j.euo.2018.02.007. Epub 2018 Jun 6. Eur Urol Oncol. 2018. PMID: 30420974 Free PMC article.
Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Ghatalia P, Gordetsky J, Kuo F, Dulaimi E, Cai KQ, Devarajan K, Bae S, Naik G, Chan TA, Uzzo R, Hakimi AA, Sonpavde G, Plimack E. Ghatalia P, et al. Among authors: devarajan k. J Immunother Cancer. 2019 Oct 22;7(1):273. doi: 10.1186/s40425-019-0735-5. J Immunother Cancer. 2019. PMID: 31640776 Free PMC article.
159 results